Prostatic Neoplasm Clinical Trials
73 clinical trials for Prostatic Neoplasm across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- PSMA PET Combined With MRI for the Detection of PCa — RECRUITING · PHASE3
- Investigation of Impact of AI on Prostate Cancer Workflow — RECRUITING · NA
- DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations — RECRUITING · PHASE2
- Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression. — RECRUITING · NA
- Impact of Augmented Reality During Robot-assisted Radical Prostatectomy — RECRUITING · NA
- Prostate Cancer Genetic Risk Evaluation and Screening Study — RECRUITING
- Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression — RECRUITING
- Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resistant Prostate Cancer — RECRUITING
- A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC — ACTIVE_NOT_RECRUITING · PHASE2
- Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate Biopsies — TERMINATED · NA
- Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors — COMPLETED · NA
- IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen — COMPLETED · PHASE2
- Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness — ACTIVE_NOT_RECRUITING · PHASE1
- EBRT + Lu-PSMA for N1M0 Prostate Cancer — COMPLETED · PHASE1
- I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW). — COMPLETED · PHASE2
- Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy — COMPLETED · PHASE1
- Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate Cancer — COMPLETED
- 177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancer — TERMINATED · PHASE1
- [68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer — ACTIVE_NOT_RECRUITING
- Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study — COMPLETED · PHASE2
- EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression — COMPLETED · NA
- Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer — COMPLETED · NA
- 68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer — COMPLETED · PHASE2
- Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors — COMPLETED · NA
- 68Ga PSMA in Preprostatectomy Patients — COMPLETED · PHASE2
- Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate — TERMINATED · PHASE2
- Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy — TERMINATED
- Urinary and Prostate Microbiotes and Prostate Cancer — COMPLETED · NA
- Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer START — COMPLETED
- MSG Use With 18F-DCFPyL PET/CT Imaging — COMPLETED · NA
- Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP — OTHER · PHASE2
- A Study on Drug-drug Interactions in Patients Treated With Anticancer Agents for a Prostate Cancer in Real Life Setting — OTHER
- The Effects of Method of Anaesthesia on the Safety and Effectiveness of Radical Retropubic Prostatectomy — COMPLETED · NA
- SLPI for Prostate Cancer — OTHER
- Trial of NanoPac Focal Therapy for Prostate Cancer — TERMINATED · PHASE2
- An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma — OTHER · PHASE2
- 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical — OTHER · NA
- Organoids From Metastases of Prostate Cancer — TERMINATED · NA
- Impact of Exercise on Prognostic Biomarkers Related to Prostate Cancer — COMPLETED · NA
- Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist. — COMPLETED · PHASE2
- Detection Rate of Prostate Cancer in Men Undergoing MRI — COMPLETED
- The Immunodynamic Effect of Radiotherapy in Prostate Cancer Patients. — OTHER · NA
- Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit — COMPLETED · PHASE1
- Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed — OTHER · NA
- HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer — OTHER · PHASE2
- Comparison of Multi-parametric and Bi-parametric Magnetic Resonance Imaging in Men With Suspicion of Prostate Cancer — COMPLETED · NA
- Carboplatin in Castration-resistant Prostate Cancer — TERMINATED · PHASE2
- Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy — TERMINATED · NA
- Urology of Virginia Case Series — COMPLETED · NA
- Open Anterograde Radical Prostatectomy Compared to Open Retrograde Technique — COMPLETED · NA
Refine this search